“…IGF-independent activities of IGFBP-2 have been suggested by its interactions with α5β1-integrin, 40 its cytosolic uptake, 41 and its nuclear translocation. 42,43 Although IGFBP-2 has been shown to inhibit proliferation in multiple cell lines in IGF-dependent cell culture systems, 41 experimentally created IGFBP-2 overexpression in vitro increased invasiveness of ovarian 44 and bladder 45 cancer cell lines, and increased proliferation of Y-1 murine adrenocortical tumor cells 46 and DU145 prostate cancer cells. 47 IGFBP-2 expression has been shown to be elevated in multiple tumors (including prostate, colon, adrenocortical, mammary, ovarian, brain, thyroid, and hepatic cancers), to often correlate positively with tumor grade and/or stage and to be increased in the serum of these patients.…”